Sandbox testing: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Label template}} =Black Box Warning= df ==Adult Indications and Dosage== dfsdf =FDA-Labeled Indications and Dosage (Adult)= sdf ==Off-Label Use and Dosage (Adult)== dsf ...") |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{Label_template | ||
|drugClass=thienopyridine | |||
|indication=ACS | |||
|blackBoxWarning=Yes | |||
|adverseReactions= increased risk of bleeding | |||
}} | |||
= | |||
= | |||
= | |||
= | |||
Latest revision as of 20:25, 18 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]{{{authorTag}}}
For information about {{{genericName}}}, click here.
Disclaimer
Overview
Sandbox testing is a thienopyridine drug that is FDA approved for the treatment of ACS. Adverse reactions include increased risk of bleeding.